Issue Open Date
|
13-Nov-24
|
Issue Closing Date
|
18-Nov-24
|
Application Money
|
100
|
Allotment Money
|
|
|
Price Band
|
58
-
61
|
Minimium Application No.
|
2000
|
Issue Size (Shares)
|
3444000
|
Market Lot
|
1
|
|
|
Objective
|
1. Upgradation of existing manufacturing Unit I to manufacture large volume parentals for intravenous use.2. Setting up a high-speed cartooning packaging line at existing manufacturing Unit II for Dry Powder Injections.3. Prepayment or repayment of all or a portion of certain loans availed by our Company.4. General Corporate Purposes.
|
|
|
|
Category
|
No. of Shares
|
No. of Shares
|
Subscription Ratio
|
|
Offered / Reserved |
Bid For |
|
Non-Institutional Investors
|
|
415166000
|
|
Qualified Institutional Buyers
|
|
29634000
|
|
Retail Individual Investors
|
|
29634000
|
|
|
|
|
Business Description
Onyx started its operation in pharmaceutical industry with sterile water for injections in the year 2010. Since then,Onyx has been associated with the healthcare segment and offering Sterile Pharmaceutical products and has becomea prominent supplier of sterile
|
|
Promoter's Holding
|
Total Share Capital
|
11803200
|
Offered to Public
|
4810000
|
Promoter's Holding (Pre-Issue)
|
88.6
|
Promoter's Holding (Post-Issue)
|
65.1
|
|
MORE > |
|
|
|
|
|
Address |
Bir Plassi Near Sainimajraropar Nalagarh Road
Solan Dist
,
Himachal Pradesh
,
174101
Phone :
Email :
generalinfo@onyxbiotec.com
Website :
www.onyxbiotec.com
|
|
Registrar |
MAS Services Ltd
T-34 2nd Floor Okhla Industrial Area Phase - II New Delhi
|
|
Listed at |
NSE
|
|
Lead Manager |
Horizon Management Pvt Ltd.
|
|
Promoters |
Fateh Pal Singh Harsh Mahajan Lakshya Jain Naresh Kumar Parmjeet Kaur Sanjay Jain
|
|